BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Adinolfi LE, Rinaldi L, Nevola R. Chronic hepatitis C, atherosclerosis and cardiovascular disease: What impact of direct-acting antiviral treatments? World J Gastroenterol 2018; 24(41): 4617-4621 [PMID: 30416309 DOI: 10.3748/wjg.v24.i41.4617]
URL: https://www.wjgnet.com/1948-5182/full/v24/i41/4617.htm
Number Citing Articles
1
Mohamed Alhefnawy, Ahmed Mohey, Ahmed Fathi, Ahmed Mansour, Sherief Abd-Elsalam, Ahmed Eissa, Ayman Hagras, Stefano Puliatti, Khaled Almekaty. Effect of Direct-Acting Antiviral Drugs on Erectile Functions among Hepatitis C Patients: A Prospective Interventional StudyEndocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(3): 310 doi: 10.2174/1871530321666210212143932
2
Rasha Eletreby, Mahmoud Anees, Mariam Naguib, Abdelrahman Kobtan, Amal Helmy, Nahla Khalaf, Shimaa Mansour, Mohamed Hassany, Wafaa El Akel, Ahmed Hashem, Wahid Doss, Gamal Esmat. The interrelation between lipid profile in chronic HCV patients and their response to antiviral agentsExpert Review of Gastroenterology & Hepatology 2021; 15(1): 103 doi: 10.1080/17474124.2020.1823831
3
Matteo Nicola Dario Di Minno, Pasquale Ambrosino, Antonio Riccardo Buonomo, Biagio Pinchera, Ilenia Calcaterra, Manuel Crispo, Riccardo Scotto, Francesco Borgia, Consalvo Mattia, Ivan Gentile. Direct-acting antivirals improve endothelial function in patients with chronic hepatitis: a prospective cohort studyInternal and Emergency Medicine 2020; 15(2): 263 doi: 10.1007/s11739-019-02163-8
4
Mohammad Said Ramadan, Filomena Boccia, Simona Maria Moretto, Fabrizio De Gregorio, Massimo Gagliardi, Domenico Iossa, Emanuele Durante-Mangoni, Rosa Zampino. Cardiovascular Risk in Patients with Chronic Hepatitis C Treated with Direct Acting AntiviralsJournal of Clinical Medicine 2022; 11(19): 5781 doi: 10.3390/jcm11195781
5
Phillip Chan, Serena Spudich. Investigating vascular diseases in people living with HIV by nuclear imagingJournal of Nuclear Cardiology 2022; 29(4): 1576 doi: 10.1007/s12350-021-02613-x
6
Rosanna Villani, Francesca Di Cosimo, Antonino Davide Romano, Moris Sangineto, Gaetano Serviddio. Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysisScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-93251-3
7
Pramod N. Kamalapathy, Sean Sequeira, Dennis Chen, Joshua Bell, Joseph S. Park, Brian C. Werner. Postoperative Complications Following Ankle Arthrodesis in Patients With Hepatitis C: Matched Propensity Score AnalysisFoot & Ankle Specialist 2021; : 193864002110539 doi: 10.1177/19386400211053943
8
Michael Broker, Shalom Z. Frager, Nayan S. Patel, Edward Lebovics, William H. Frishman. The Inflammatory Relationship Between Hepatitis C Virus With Coronary and Carotid AtherosclerosisCardiology in Review 2021; 29(4): 178 doi: 10.1097/CRD.0000000000000314
9
Evangelista Sagnelli, Caterina Sagnelli, Antonio Russo, Mariantonietta Pisaturo, Clarissa Camaioni, Roberta Astorri, Nicola Coppola. Advances in Microbiology, Infectious Diseases and Public HealthAdvances in Experimental Medicine and Biology 2020; 1323: 115 doi: 10.1007/5584_2020_604
10
Iman Ibrahim Salama, Hala M Raslan, Ghada A Abdel-Latif, Somaia I Salama, Samia M Sami, Fatma A Shaaban, Aida M Abdelmohsen, Walaa A Fouad. Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infectionWorld Journal of Hepatology 2022; 14(6): 1053-1073 doi: 10.4254/wjh.v14.i6.1053
11
Yu‐Hsuan Hsiao, Wei‐Ming Chen, Chia‐Hao Chang, Mei‐Yen Chen. Future outcomes and health needs of chronic hepatitis C patients after receiving antiviral therapyJournal of Advanced Nursing 2021; 77(8): 3370 doi: 10.1111/jan.14850
12
Michael R Goetsch, Ashutosh Tamhane, Edgar T Overton, Graham C Towns, Ricardo A Franco. Direct Acting Antivirals in Hepatitis C-Infected Kidney Transplant Recipients: Associations with Long-term Graft Failure and Patient MortalityPathogens and Immunity 2020; 5(1): 275 doi: 10.20411/pai.v5i1.369
13
Raynell Lang, Elizabeth Humes, Brenna Hogan, Jennifer Lee, Ralph D'Agostino, Joseph Massaro, Arthur Kim, James B. Meigs, Leila Borowsky, Wei He, Asya Lyass, David Cheng, H. Nina Kim, Marina B. Klein, Edward R. Cachay, Ronald J. Bosch, M. John Gill, Michael J. Silverberg, Jennifer E. Thorne, Kathleen McGinnis, Michael A. Horberg, Timothy R. Sterling, Virginia A. Triant, Keri N. Althoff. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus CoinfectionJournal of the American Heart Association 2022; 11(19) doi: 10.1161/JAHA.122.026473
14
Jose Gabriel Solis, Ervin Saul Enciso López, Aleida Bautista Santos, Juan Carlos Anda Garay, Jose Luis Calixto Rodríguez, Rosalba Moreno Alcántar, Luis Montiel López. Effect of Antiviral Agents on Atherosclerosis in Patients with Chronic Hepatitis CArchives of Medical Research 2021; 52(7): 764 doi: 10.1016/j.arcmed.2021.04.009
15
Loreta A. Kondili, Massimo Andreoni, Alfredo Alberti, Salvatore Lobello, Sergio Babudieri, Antonella De Michina, Rocco Merolla, Walter Marrocco, Antonio Craxì. A mathematical model by route of transmission and fibrosis progression to estimate undiagnosed individuals with HCV in different Italian regionsBMC Infectious Diseases 2022; 22(1) doi: 10.1186/s12879-022-07042-w
16
Nadia Marascio, Salvatore Rotundo, Angela Quirino, Giovanni Matera, Maria Carla Liberto, Chiara Costa, Alessandro Russo, Enrico Maria Trecarichi, Carlo Torti. Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice World Journal of Gastroenterology 2022; 28(12): 1226-1238 doi: 10.3748/wjg.v28.i12.1226
17
Alison L. Bailey, Saif Al-Adwan, Eliea Sneij, Nicholas Campbell, Matthew E. Wiisanen. Atherosclerotic Cardiovascular Disease in Individuals with Hepatitis C Viral InfectionCurrent Cardiology Reports 2021; 23(5) doi: 10.1007/s11886-021-01475-6
18
Mohamed A. Abd El Hafez, Zeinab Abdel Aziz Kasemy. Effect of direct-acting antivirals on platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with hepatitis C virus-related thrombocytopeniaThe Egyptian Journal of Internal Medicine 2019; 31(3): 296 doi: 10.4103/ejim.ejim_14_19
19
Petr Husa, Svatava Snopkova, Jirina Zavrelova, Filip Zlamal, Radek Svacinka, Petr Husa. Circulating microparticles in patients with chronic hepatitis C and changes during direct-acting antiviral therapyBiomedical Papers 2021; 165(2): 146 doi: 10.5507/bp.2021.023
20
Irina Gîrleanu, Anca Trifan, Laura Huiban, Cristina Muzîca, Oana Cristina Petrea, Ana Maria Sîngeap, Camelia Cojocariu, Stefan Chiriac, Tudor Cuciureanu, Irina Iuliana Costache, Carol Stanciu. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to InjuryLife 2022; 12(7): 1036 doi: 10.3390/life12071036
21
Preetha Rajkumar, Alok Kumar Dwivedi, Christopher Alfred Dodoo, Navkiran Kaur Shokar, Jennifer Salinas, Rajkumar Lakshmanaswamy. The association between metabolic syndrome and Hepatitis C virus infection in the United StatesCancer Causes & Control 2020; 31(6): 569 doi: 10.1007/s10552-020-01300-5
22
Mohammad Haykal, Akira Matsumori, Ahmed Saleh, Moatez Fayez, Hany Negm, Mohammad Shalaby, Samar Bassuony. Diagnosis and treatment of HCV heart diseasesExpert Review of Cardiovascular Therapy 2021; 19(6): 493 doi: 10.1080/14779072.2021.1917383
23
Nirupma Singh, Sneha Rai, Rakesh Bhatnagar, Sonika Bhatnagar. Network analysis of host-pathogen protein interactions in microbe induced cardiovascular diseasesIn Silico Biology 2022; 14(3-4): 115 doi: 10.3233/ISB-210238